SCHEMBL18152624

SCHEMBL18152624

CSCc1c(CC2CC2)c(Br)cc2[nH]c(C)nc12

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.33
▸ ADRB2 P07550 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18152677 0.87 CCNB2 (0.32) —
SCHEMBL18152659 0.81 ADRB2 (0.33) HTTADRB2
SCHEMBL18152712 0.77 GRIN2D (0.38) HTT
SCHEMBL18152627 0.72 CCNB2 (0.31) —
SCHEMBL18152638 0.67 SMN1; SMN2 (0.41) HTTADRB2
SCHEMBL4381077 0.63 HTT (0.47) HTT
SCHEMBL13544184 0.60 SMN1; SMN2 (0.50) HTT
SCHEMBL14722325 0.58 HTT (0.68) HTT
SCHEMBL15023422 0.58 HTT (0.44) HTT
SCHEMBL17875694 0.58 CSNK2A1 (0.46) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283077-A2 BROMODOMAIN INHIBITOR Celgene Quanticel Research, Inc. (US) 2018-02-21 — — EP disclosed
WO-2016168682-A2 BROMODOMAIN INHIBITOR CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-20 — — WO disclosed
Send feedback